Early Research in Autoimmune Disease & Fibromyalgia What It Shows and Why Its Limited Fibromyalgia: Early Signals, No Conclusions Some observational reports describe symptom improvements (pain, fatigue, opioid use) in people taking GLP-1 medications, but limitations are consistent: non-randomized design, small samples, and confounding from weight loss, sleep, and metabolic improvements
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
Intra-islet GLP-1, but not CCK, is necessary for beta-cell function in mouse and human islets
Despite such a complex three-level care organization and the opportunities offered by technological advances, LD still frequently occurs because of improper insulin injection technique
Abstract Purpose of Review Hypertension is the leading modifiable risk factor for cardiovascular disease